Trial Profile
Observational study of the effects of probenecid on the pharmacokinetics and pharmacodynamics of sorafenib (PROSORA-study)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2017
Price :
$35
*
At a glance
- Drugs Probenecid (Primary) ; Sorafenib (Primary)
- Indications Liver cancer; Renal cell carcinoma; Thyroid cancer
- Focus Pharmacokinetics
- Acronyms PROSORA
- 29 Nov 2017 New trial record